Description

This edition of the Genetic Technology TOE depicts the new life sciences trends across biotherapies. Different cutting-edge technologies such as nanotechnologies and next-generation antibodies are profiled. The corresponding patent scenario related to viral immunotherapies is depicted, along with the industry interactions.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Smart nanoparticles, cancer therapy, oncolytic viral therapies, monoclonal antibodies, immuno-oncology